Condition: Tuberculosis · Sponsor: University of California, San Francisco
Every year, more than 3 million people with TB remain undiagnosed and 1 million die. Better diagnostics are essential to reducing the enormous burden of TB worldwide. The Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT) study seeks to reduce the burden of TB worldwide by evaluating faster, simpler, and less expensive TB triage and diagnostic tests.
This description comes directly from the study's public registry record.
Adithya Cattamanchi · +1-415-206-5489 · adithya.cattamanchi@ucsf.edu
Catherine Cook · 603-988-9940 · Catherine.Cook@ucsf.edu
Always discuss trial participation with your own doctor first.
| Zankli Research Center, Bingham University | Abuja, Nigeria | Recruiting |
| De La Salle Medical and Health Sciences Institute | Dasmariñas, Philippines | Recruiting |
| Centre for Infectious Disease Research in Zambia | Lusaka, Zambia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05941052